دورية أكاديمية

Localized delivery of ibuprofen via a bilayer delivery system (BiLDS) for supraspinatus tendon healing in a rat model.

التفاصيل البيبلوغرافية
العنوان: Localized delivery of ibuprofen via a bilayer delivery system (BiLDS) for supraspinatus tendon healing in a rat model.
المؤلفون: Taylor, Brittany L., Kim, Dong Hwa, Huegel, Julianne, Raja, Harina A., Burkholder, Sophie J., Weiss, Stephanie N., Nuss, Courtney A., Soslowsky, Louis J., Mauck, Robert L., Kuntz, Andrew F., Bernstein, Joseph
المصدر: Journal of Orthopaedic Research; Nov2020, Vol. 38 Issue 11, p2339-2349, 11p
مصطلحات موضوعية: TENDON injury healing, ACHILLES tendon, ROTATOR cuff, ETHYLCELLULOSE, RATS, ANTI-inflammatory agents
مستخلص: The high prevalence of tendon retear following rotator cuff repair motivates the development of new therapeutics to promote improved tendon healing. Controlled delivery of non‐steroidal anti‐inflammatory drugs to the repair site via an implanted scaffold is a promising option for modulating inflammation in the healing environment. Furthermore, biodegradable nanofibrous delivery systems offer an optimized architecture and surface area for cellular attachment, proliferation, and infiltration while releasing soluble factors to promote tendon regeneration. To this end, we developed a bilayer delivery system (BiLDS) for localized and controlled release of ibuprofen (IBP) to temporally mitigate inflammation and enhance tendon remodeling following surgical repair by promoting organized tissue formation. In vitro evaluation confirmed the delayed and sustained release of IBP from Labrafil‐modified poly(lactic‐co‐glycolic) acid microspheres within sintered poly(ε‐caprolactone) electrospun scaffolds. Biocompatibility of the BiLDS was demonstrated with primary Achilles tendon cells in vitro. Implantation of the IBP‐releasing BiLDS at the repair site in a rat rotator cuff injury and repair model led to decreased expression of proinflammatory cytokine, tumor necrotic factor‐α, and increased anti‐inflammatory cytokine, transforming growth factor‐β1. The BiLDS remained intact for mechanical reinforcement and recovered the tendon structural properties by 8 weeks. These results suggest the therapeutic potential of a novel biocompatible nanofibrous BiLDS for localized and tailored delivery of IBP to mitigate tendon inflammation and improve repair outcomes. Future studies are required to define the mechanical implications of an optimized BiLDS in a rat model beyond 8 weeks or in a larger animal model. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Orthopaedic Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:07360266
DOI:10.1002/jor.24670